NightWare, Inc

Therapeutic to treat nightmares, namely as a result of PTSD. Utilizes machine learning and wearable technology.

  • Stage Full Product Ready
  • Industry Healthcare Services
  • Location Minneapolis, MN, US
  • Currency USD
  • Founded September 2015
  • Employees 5
  • Incorporation Type C-corp
  • Website nightware.com

Company Summary

NightWare is a therapeutic that utilizes machine learning to treat patients with nightmares, primarily as a result of PTSD. The app uses wearable sensors to detect nightmares, and once a nightmare is detected the app arouses the sleeper out of the nightmare without waking them up. Preliminary results are promising, and NightWare is in clinical trial with HCMC. Company is in presubmission process for FDA approval.

Team

  • Grady Hannah
    CEO

    15 year Business Development Exec for early stage Silicon Valley start ups. 2 companies exited through acquisition to CA and NVIDIA.

  • Melissa Byrd
    Chief Marketing Officer

    15Y medical device marketing
    5Y patient care at top US hospital (registered dietitian)

  • Randy Milbert
    Chief Technical Officer

    MIT graduate. Built Primordial from inception to successful exit to Polaris. Winner of 15 SBIR and DoD contracts. Holds 10 patents in advanced software algorithms.

  • Daniel Karlin
    Chief Medical Officer

    Former Director of Mobile Clinical Informatics at Pfizer, Global Clinical Lead on FAAH Inhibitor drug seeking PTSD indication at Pfizer, Psychiatrist, Digital Health and Digital Therapeutics leader

Previous Investors

  • Norbert Berg
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free